Followers | 184 |
Posts | 4438 |
Boards Moderated | 2 |
Alias Born | 01/08/2018 |
Tuesday, February 11, 2020 2:21:38 PM
Dr Joseph Kim: (CEO)
Created the PCV1 PCV2 Porcine Circovirus (PIG DNA) A couple of years after they were given the patent for this pig DNA vaccine using PCV2 that same ingredient was found to be in Merck’s $MRK Rotarix vaccine for diarrhoea and GSK vaccine Rotateq for diarrhoea Merck $MRK helped fund Dr. Kim for the creation of PCV1, PCV2
Dr. Kim has many Merck $MRK Insiders on his board
founder of VGXI, Inc.
Dr. Weiner:
A pioneer of DNA vaccinations, A leading DNA technology inventor the worlds DNA technology expert but he is also a special employee and adviser to the FDA and the NIH grant review process.
HIV pioneer.
He has perfected a new method of giving these DNA vaccines via Electroporation.
Dr. Weiner was highly involved in the Zika vaccine.
An advisor to GSK, Pfizer and other Pharma giants.
founder of VGXI, Inc.
They was one of the very first to genetically modified a virus, used in this case was on pigs.
In 2006 VGXI, Inc were providing HIV vaccines in Africa.
In 2008, VGXI, Inc, which is also owned by Inovio, went into an arrangement to manufacture DNA plasmid for human use.
In 2009, Inovio filed a IND with FDA to start trials on humans with a DNA vaccine for H5N1.
Their lead drug for Swine flu was licensed in 2009.
In 2010, 8 different plasmids were produced in a study provided by the Defence threat Reduction Agency of the DoD.
In 2011 they were working with Homeland security on Foot and mouth disease.
New strains of foot and mouth disease began in 2012 in USA.
Solution before the problem started...
Under a research and development agreement, they were working with US Dept of homeland security and Plum Island Animal disease center.
They were then given the go ahead to produce not only the Ebola vaccines but also the new novel method to administer them.
The Wistar Institute (The Weiner Laboratory) were given 9 million dollars to advance a coronavirus vaccine, the institute has Dr. Weiner as the executive vice president, who's company will then make a profit from the vaccine. https://wistar.org/our-scientists/david-weiner
How do you think the grant money was given to them so fast? $9 million grant from CEPI. The grant builds on Inovio’s existing partnership with CEPI (up to $56 million grant) No wonder then, Inovio was given a $28 million dollar grant by the NIH to develop its genetically modified DNA based monoclonal antibodies and its new process of electroporation.
Inovio estimates the vaccine will be available for human testing by early summer
Recent INO News
- INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants • PR Newswire (US) • 04/15/2024 10:39:00 PM
- INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine • PR Newswire (US) • 03/26/2024 10:28:00 PM
- INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights • PR Newswire (US) • 03/06/2024 09:05:00 PM
- Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting • PR Newswire (US) • 03/06/2024 12:00:00 PM
- U.S. Stock Futures Gain Ahead of Economic Insights; Oil Prices Climb • IH Market News • 03/06/2024 11:02:03 AM
- INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024 • PR Newswire (US) • 02/21/2024 01:00:00 PM
- INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • PR Newswire (US) • 02/07/2024 04:46:00 PM
- INOVIO Reports Inducement Grant Under Inducement Plan • PR Newswire (US) • 02/02/2024 01:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/01/2024 05:15:24 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:01:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:02:31 PM
- INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split • PR Newswire (US) • 01/23/2024 01:00:00 PM
- INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader • PR Newswire (US) • 01/22/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 10:27:59 PM
- INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi) • PR Newswire (US) • 01/04/2024 01:00:00 PM
- INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program • PR Newswire (US) • 01/03/2024 01:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2023 09:05:57 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/17/2023 09:00:28 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/09/2023 09:35:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:15:59 PM
- INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights • PR Newswire (US) • 11/09/2023 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:00:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:01:55 PM
- INOVIO Reports Inducement Grants Under Inducement Plan • PR Newswire (US) • 11/01/2023 12:00:00 PM
- INOVIO to Report Third Quarter 2023 Financial Results on November 9, 2023 • PR Newswire (US) • 10/26/2023 12:00:00 PM
FEATURED Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • Apr 22, 2024 8:49 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM